Chemoinformaics analysis of Bisabolol
Molecular Weight | 222.372 | nRot | 4 |
Heavy Atom Molecular Weight | 196.164 | nRig | 7 |
Exact Molecular Weight | 222.198 | nRing | 1 |
Solubility: LogS | -4.9 | nHRing | 0 |
Solubility: LogP | 5.369 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 43.1886 |
nHD | 1 | BPOL | 26.0834 |
QED | 0.706 |
Synth | 3.673 |
Natural Product Likeliness | 2.814 |
NR-PPAR-gamma | 0.005 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.19 |
Pgp-sub | 0.001 |
HIA | 0.006 |
CACO-2 | -4.42 |
MDCK | 0.0000197 |
BBB | 0.191 |
PPB | 0.956852 |
VDSS | 3.76 |
FU | 0.0396429 |
CYP1A2-inh | 0.648 |
CYP1A2-sub | 0.224 |
CYP2c19-inh | 0.393 |
CYP2c19-sub | 0.833 |
CYP2c9-inh | 0.245 |
CYP2c9-sub | 0.875 |
CYP2d6-inh | 0.064 |
CYP2d6-sub | 0.145 |
CYP3a4-inh | 0.105 |
CYP3a4-sub | 0.179 |
CL | 10.303 |
T12 | 0.23 |
hERG | 0.02 |
Ames | 0.003 |
ROA | 0.006 |
SkinSen | 0.935 |
Carcinogencity | 0.152 |
EI | 0.971 |
Respiratory | 0.027 |
NR-Aromatase | 0.027 |
Antiviral | Yes |
Prediction | 0.822863 |